cytk stock
Trending on Tuesday, May 5, 2026
Peak Traffic
200+
News Articles
3
Country
US
Related News
Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy
Cytokinetics
Read more
Cytokinetics drug Myqorzo meets twin efficacy goals in study of genetic heart disease
STAT
Read more
Cytokinetics' Myqorzo succeeds in landmark cardiomyopathy trial
Fierce Pharma
Read more